@article{2b827b5c5b2a4917bcf5a6865f6d2cc6,
title = "The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors",
abstract = "This manuscript is the result of the North American Neuroendocrine Tumor Society consensus conference on the surgical management of pancreatic neuroendocrine tumors from July 19 to 20, 2018. The group reviewed a series of questions of specific interest to surgeons taking care of patients with pancreatic neuroendocrine tumors, and for each, the available literature was reviewed. What follows are these reviews for each question followed by recommendations of the panel.",
keywords = "metastases, neuroendocrine, neuroendocrine tumor liver metastases, pancreas, pancreatectomy, pancreatic neuroendocrine tumor",
author = "Howe, {James R.} and Merchant, {Nipun B.} and Claudius Conrad and Keutgen, {Xavier M.} and Julie Hallet and Drebin, {Jeffrey A.} and Minter, {Rebecca M.} and Lairmore, {Terry C.} and Tseng, {Jennifer F.} and Zeh, {Herbert J.} and Libutti, {Steven K.} and Gagandeep Singh and Lee, {Jeffrey E.} and Hope, {Thomas A.} and Kim, {Michelle K.} and Yusuf Menda and Halfdanarson, {Thorvardur R.} and Chan, {Jennifer A.} and Pommier, {Rodney F.}",
note = "Funding Information: Conferences, NETRF, NCAN, and ENETS). X.M.K. received consulting honoraria from Advanced Accelerator Applications. J.H. has received speaking honoraria from Ipsen Biopharmaceuticals Canada and Novartis Oncology, and travel support from Baxter Corporation. J.A.D. owns shares in biotech firms (ALNYand IONS) and his spouse is chief medical officer for American Regent Pharmaceuticals. R.M.M. has received travel expenses and/or honoraria for speaking at academic centers and meetings of the American Board of Surgery, National Board of Medical Examiners, Society of University Surgeons, Americas Hepatopancreatobiliary Association, International Hepatopancreatobiliary Association Fellowship Council, and Royal Australasian College of Surgeons. J.F.T. has received a research grant from Mauna Kea Technologies, Inc. H.J.Z. has received a research funding from Intuitive Surgical Inc., and travel expenses for independent symposium on robotics and HPB surgery. T.A.H. was on the advisory board and a consultant for Curium, Inc. M.K.K. received research funds from Novartis. Y.M. has received research funding from Ipsen and Advanced Accelerator Applications. T.R.H. has received research funding from Ipsen and Thermo Fisher Scientific, and has served on the advisory boards of Ipsen, Curium, Novartis, and Lexicon. J.A.C. is a consultant and advisory board member of Crinetics, Ipsen, Novartis, and Lexicon; she receives royalties from UpToDate, and owns stock in Merck. R.F.P. is a consultant to Novartis, Lexicon, and Advanced Accelerator Applications. The other authors declare no conflict of interest. Publisher Copyright: {\textcopyright} 2020 Wolters Kluwer Health, Inc. All rights reserved.",
year = "2020",
month = jan,
day = "1",
doi = "10.1097/MPA.0000000000001454",
language = "English (US)",
volume = "49",
pages = "1--33",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "1",
}